Tuesday, August 18, 2026
ExploreSearch
Finance Via News
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Enterprise AI Agent Rollout Outpaces Data Trust and Readiness
Enterprise adoption of agentic AI is accelerating fast — Siemens deepening its NVIDIA partnership for self-verifying agentic AI in chip design, Manulife expanding its Microsoft AI-governance partnership, and a wave of infrastructure launches (NVIDIA GPU-accelerated data processing, Dell exascale storage, new AI chip generations) — even as a new Google Cloud survey shows the underlying data foundation isn't ready: companies have AI access to only 45% of their data on average, data laggards see access fall to 30% or less, and only about half of organizations trust their AI agents' decisions. Meanwhile, insider selling at enterprise-AI bellwether C3.ai (CEO Thomas Siebel offloading $4.8M in shares) hints at investor caution layered under the adoption hype.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
JPMorgan Chase & Co.
Both facts report JPMorgan Chase & Co.'s revenue for the same fiscal period (FY 2025) with the same observation date (2025-12-31), but with different values: $182.447 billion vs. $185 billion. The ~1.4% difference ($2.553 billion) is too large to be explained by rounding alone and represents conflicting data for the identical time period.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,812
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,812 facts checked against source5,219 source documents archived
Work with this data → vianewsagency.com
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Press releaseGlobeNewswire· February 9, 2026

dsm-firmenich announces agreement to divest Animal Nutrition & Health to CVC Capital Partners

View original at globenewswire.com
dsm-firmenich announces agreement to divest Animal Nutrition & Health to CVC Capital Partners Press Release dsm-firmenich announces agreement to divest Animal Nutrition & Health to CVC Capital Partners Kaiseraugst (Switzerland), Maastricht (Netherlands), February 9, 2026 dsm-firmenich, innovators in nutrition, health,…
Opening lines of the source · GlobeNewswire · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • This agreement opens an exciting new chapter for ANH, enabling it to thrive and realize its full potential

    80% confidence

  • dsm-firmenich expects to receive approximately €1.2 billion after closing of which an estimated €0.6 billion in net cash proceeds, an estimated €0.5 billion in debt and liability transfers to the ANH Companies, and €0.1 billion in the form of a vendor loan note

    80% confidence

  • dsm-firmenich expects to incur cash tax, transaction and separation costs of €0.2 billion in 2026

    80% confidence

  • The Solutions Company will continue to drive innovation and efficiency in animal farming, delivering tailored solutions with high proximity to its global customer base

    80% confidence

  • The Essential Products Company will be built as a resilient global leader in essential feed, food and fragrance ingredients, providing customers with reliable, high-quality supply based on an independent and highly integrated value chain

    80% confidence

  • Since the creation of dsm-firmenich, we have consistently delivered on every milestone in our strategic roadmap. This transaction marks the final step in that journey and reflects our commitment to accelerating our growth and creating long-term value for all stakeholders.

    80% confidence

  • The transaction is expected to be completed at the end of 2026 and is subject to conditions including regulatory approvals, finalization of employee consultation processes and creation and separation of standalone companies

    80% confidence

  • This transaction represents a unique opportunity to create two new leading companies in the animal nutrition & health space with significant potential for value creation

    80% confidence

Cited in these Via News reports